+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Organs - Global Strategic Business Report

  • PDF Icon

    Report

  • 288 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 362119
The global market for Artificial Organs is estimated at US$23.4 Billion in 2023 and is projected to reach US$38.9 Billion by 2030, growing at a CAGR of 6.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Artificial Kidneys segment, which is expected to reach US$20.9 Billion by 2030 with a CAGR of 7.1%. The Artificial Pancreas segment is also set to grow at 6.2% CAGR over the next 8 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $6.9 Billion in 2023, and China, forecasted to grow at an impressive 6.1% CAGR to reach $6.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Artificial Organs Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Artificial Organs Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Artificial Organs Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Abiomed Inc., Asahi Kasei Medical Co., Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 71 Featured):

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Recent Market Activity
  • Artificial Organs Revolutionize Medical Industry
  • Growth Drivers
  • Growth Inhibitors
  • Artificial Organs Poised to Witness Significant Demand
  • The United States - A Dominant Force in the Artificial Organs Market
  • Artificial Kidneys Garner a Larger Pie in the Artificial Organs Market
  • Demand and Supply Imbalance
  • Competitive Scenario
  • Technological Advancements Spearheading Growth
  • Artificial Organs - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
  • ABBOTT (USA)
  • Abiomed, Inc. (USA)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Baxter International, Inc. (USA)
  • F.Hoffmann-La Roche Ltd. (Switzerland)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Jarvik Heart, Inc. (USA)
  • Medtronic, Inc. (USA)
  • HeartWare International, Inc. (USA)
  • Nikkiso Co., Ltd. (Japan)
  • Nipro Corporation (Japan)
  • SynCardia Systems, LLC (USA)
  • Toray Medical Co., Ltd. (Japan)
  • Xenios AG (Germany)
3. MARKET TRENDS & DRIVERS
  • Increasing Incidence of Cardiovascular Disease Drive the Market for Artificial Heart and VAD
  • Higher Development Costs and Lengthy Regulatory Process - Stumbling Blocks for Product Commercialization
  • Lack of Requisite Expertise - Hindering Implantation Process
  • Xenotransplantation - Other Alternative to Donor Organ Shortage
  • Artificial Organs from Cloned Animal Cells - A Promising Trend
  • Immunosuppressants Hold Promise in Artificial Organs Market
  • Move towards Smaller ImplanTable Devices
  • Barriers to Entry Significantly High in Dialyzers Market
  • Reuse of Dialyzers - A Major Issue in Dialysis Industry
  • Poor Reimbursement Environment Stymies Innovation
  • Product Recalls - A Major Blow to the Manufacturers
  • Higher Cost of Artificial Organs Hampers Broader Adoption
  • Major Issues Related to Artificial Organs
  • Financial
  • Legal
  • Ethical
  • Social
  • UCLA Researchers Develop Cancer-Fighting Cells
  • Production of 3D-like Artificial Organs in a Device that Works like a Cotton Candy Machine
  • Harvard Scientists Create Tissue Containing Blood Vessels
  • University of Washington Researchers Create Communicating Yeast Cells
  • Scientists Define Morphospace to Evaluate Viability of Artificial Organs
  • Application of 3D-Printing in the Medical Field
  • 3D Printing Revolutionizing the Medical Industry's Artificial Organ Development Segment
"Soft" 3D Bioprinting Eliminates Concerns of Hard Plastic-based Organ Models
  • 3D Printed Organ Models with Sensors Enable Real-time Feedback
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Artificial Kidneys by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Artificial Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Artificial Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Artificial Lungs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Artificial Organs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: Canada Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: Canada 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
JAPAN
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 26: Japan Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Japan Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Japan 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
CHINA
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 29: China Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: China Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: China 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
EUROPE
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 32: Europe Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Europe 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 35: Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
FRANCE
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 38: France Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: France Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: France 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
GERMANY
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 41: Germany Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: Germany Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Germany 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
ITALY
  • Table 44: Italy Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Italy Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Italy 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 47: UK Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: UK Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: UK 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Rest of Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Asia-Pacific 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 56: Rest of World Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Rest of World Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Rest of World 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

Table Information